Role of US military research programs in the development of US Food and Drug Administration-approved antimalarial drugs

Clinical Infectious Diseases

Volumn 43, Issue 1, 2006, Pages 67-71

  Kitchen, Lynn W ^a   Vaughn, David W ^a   Skillman, Donald R ^b  

^a U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ATOVAQUONE PLUS PROGUANIL; AZITHROMYCIN; CHLOROQUINE; CHLOROQUINE PLUS PRIMAQUINE; DOXYCYCLINE; ERYTHROMYCIN; FANSIDAR; HALOFANTRINE; MALARIA VACCINE; MALOPRIM; MEFLOQUINE; PRIMAQUINE; PROGUANIL; QUININE; TAFENOQUINE; UNCLASSIFIED DRUG;

CARDIOTOXICITY; DIARRHEA; DRUG APPROVAL; DRUG EFFICACY; DRUG FATALITY; DRUG INDUSTRY; EMBRYOTOXICITY; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL SYMPTOM; HEALTH PROGRAM; HEMOLYTIC ANEMIA; HUMAN; MALARIA; NEUROTOXICITY; NONHUMAN; PHOTOTOXICITY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; SOLDIER; STEVENS JOHNSON SYNDROME; TOOTH DISCOLORATION; UNITED STATES; UNSPECIFIED SIDE EFFECT;

ANTIMALARIALS; DRUG APPROVAL; HUMANS; MALARIA; MILITARY MEDICINE; MILITARY PERSONNEL; RESEARCH; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33745307269     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/504873     Document Type: Review

References (31)

1. Bwire R. Bugs in armor: a tale of malaria and soldiering. San Jose: iUniverse.com, 1999.
2. Wallace MR, Sharp TW, Smoak B, et al. Malaria among United States troops in Somalia. Am J Med 1996; 100:49-55.
3. Malaria outbreak among members of JTF Liberia: consensus conference report (9 October 2003). Available at: http://www-nehc.med.navy.mil/downloads/ prevmed/JTFMalaria.pdf. Accessed 7 December 2005.
4. Guerra F. The introduction of cinchona in the treatment of malaria. J Trop Med Hyg 1977; 80:112-8, 135-40.
5. Honigsbaum M. The fever trail: in search of the cure for malaria. New York: Farrar, Straus and Giroux, 2002.
6. Smith DC. Quinine and fever: the development of the effective dosage. J Hist Med Allied Sci 1976; 31:343-67.
7. Ockenhouse CF, Magill A, Smith D, Milhous W. History of US military contributions to the study of malaria. Military Medicine 2005; 170(4 Suppl):12-6.
8. Phillips RE, Warrell DA, White NJ, Looareesuwan S, Karbwang J. Intravenous quinidine for the treatment of severe falciparum malaria: clinical and pharmacokinetic studies. N Engl J Med 1985; 312:1273-8.
9. Centers for Disease Control and Prevention. Treatment with quinidine gluconate of persons with severe plasmodium falciparum infection: discontinuation of parenteral quinine from CDC Drug Service. MMWR Recomm Rep 1991; 40(RR-4):21-3.
10. Magill A, Panosian C. Making antimalarial agents available in the United States. N Engl J Med 2005; 353:335-7.
11. Pullman, TN, Craige B, Alving AS, Whorton CM, Jones R, Eichelberger L. Comparison of chloroquine, quinacrine (atabrine), and quinine in the treatment of acute attacks of sporozoite-induced vivax malaria (Chesson strain). J Clin Invest 1948; 27:46-50.
12. Garrison PL, Hankey DD, Walter GC. Cure of Korean vivax malaria with pamaquine and primaquine. JAMA 1952; 149:1562-3.
13. Carson PE, Flanagan CL, Ickes CE, Alving AS. Enzymatic deficiency in primaquine-sensitive erythrocytes. Science 1956; 124:484-5.
14. CDC travelers' health: yellow book, chapter 4 (prevention of specific infectious diseases)-malaria. Available at: http://www2.ncid.cdc.gov/travel/yb/ utils/ybGet.asp?section = dis&obj = index.htm. Accessed 21 February 2006.
15. Baird JK, Fryauff DJ, Basri H, et al. Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Java, Indonesia. Am J Trop Med Hyg 1995; 52:479-84.
16. Fryauff DJ, Baird JK, Basri H, et al. Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet 1995; 346:1190-3.
17. Shanks GD, Oloo AJ, Aleman GM, et al. A new primaquine analogue, tafenoquine (WR 238605) for prophylaxis against Plasmodium falciparum malaria. Clin Infect Dis 2001; 33:1968-74.
18. Maier J, Riley E. Inhibition of antimalarial action of sulfonamides by p-aminobenzoic acid. Proc Soc Exp Biol Med 1942; 50:152-4.
19. Ognibene AJ. Agranulocytosis due to dapsone. Ann Int Med 1970; 72:521-4.
20. Nguyen-Dinh P, Spencer HC, Chemangey-Masaba S, Churchill FC. Susceptibility of Plasmodium falciparum to pyrimethamine and sulfadoxine/pyrimethamine in Kisumu, Kenya. Lancet 1982; 1:823-5.
21. Smoak BL, Writer JV, Keep LW, Cowan J, Chantelois JL. The effects of inadvertent exposure of mefloquine chemoprophylaxis on pregnancy outcomes and infants of US Army servicewomen. J Infect Dis 1997; 176:831-3.
22. Palmer KJ, Holliday SM, Brogden RN. Meflcquine: a review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1993; 45:430-75.
23. Bryson HM, Goa KL. Halofantrine: a review of its antimalarial activity, pharmacokinetic properties and therapeutic potential. Drugs 1992; 43:236-58.
24. Pang L, Limsomwong N, Singharaj P. Prophylactic treatment of vivax and falciparum malaria with low-dose doxycycline. J Infect Dis 1988; 158:1124-7.
25. Pang LW, Limsomwong N, Boudreau EF, Singharaj P. Doxycycline prophylaxis for falciparum malaria. Lancet 1987; 1:1161-4.
26. Andersen SL, Ager A, McGreevy P, et al. Activity of azithromycin as a blood schizonticide against rodent and human plasmodia in vivo. Am J Trop Med Hyg 1995; 52:159-61.
27. Andersen SL, Oloo AJ, Gordon DM, et al. Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya. Clin Infect Dis 1998; 26:146-50.
28. Taylor WR, Richie TL, Fryauff DJ, et al. Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia. Clin Infect Dis 1999; 28:74-81.
29. Ohrt C, Willingmyre GD, Lee P, Knirsch C, Milhous W. Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. Antimicrob Agents Chemother 2002; 46:2518-24.
30. Curd FHS, Davey DG, Rose FL. Studies on synthetic antimalarial drugs: some biguanide derivatives as new types of antimalarial substances with both therapeutic and causal prophylactic activity. Ann Trop Med Parasatol 1945; 29:208-16.
31. de Alencar FE, Cerutti C, Durlacher RR, et al. Atovaquone and proguanil for the treatment of malaria in Brazil. J Infect Dis 1997; 175:1544-7.